Melatal (Melatonin)

Melatonin works by binding to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus. This activation signals the body that it is nighttime, helping to synchronize the internal clock and promote the physiological processes that lead to sleep onset and maintenance.

The appropriate dose of Melatal is determined by a qualified prescriber based on the patient’s age, condition, and response to therapy. Dosage recommendations are not standardized in public literature and should follow the prescribing information provided by the healthcare professional.

Safety data for melatonin use in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a healthcare provider after a thorough risk‑benefit assessment.

To order Melatal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details and any necessary import documentation.

Unlike benzodiazepines or non‑benzodiazepine hypnotics, melatonin works by normalising the circadian rhythm rather than depressing the central nervous system. This mechanism generally results in fewer next‑day residual effects, but efficacy may be limited to disorders directly linked to rhythm disruption, whereas other agents may be more suitable for severe insomnia.

Melatal should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct light, and ensure the packaging remains tightly closed until use to maintain stability.

Melatal is taken orally, usually as a tablet or capsule, with water. It is commonly taken shortly before bedtime, but the exact timing and any specific administration instructions should be followed as directed by the prescribing clinician.

Serious risks, although rare, include allergic reactions such as rash, swelling, or difficulty breathing, and significant mood changes like depression or agitation. Patients should seek immediate medical attention if they experience any of these symptoms while using melatonin.

Melatal should be avoided by individuals with known hypersensitivity to melatonin, those taking certain anticoagulants or immunosuppressants without medical supervision, and pregnant or breastfeeding women unless a healthcare professional determines that the benefits outweigh the risks.